Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-08

Clinical Trial Update: A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia [NA]

View source ↗

Summary

A completed pilot clinical trial evaluated eicosapentaenoic acid (EPA) for cancer cachexia; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eicosapentaenoic acid (eicosapentaenoic acid)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Cancer Cachexia | NA | Status: COMPLETED | Results posted: 2011-09-08